Gastroenterology
News from the FDA/CDC
FDA puts hold on esophagitis, H. pylori drug, owing to impurity concerns
The manufacturer was asked to provide “additional stability data to demonstrate that levels of the impurity previously found in vonoprazan drug...
News
Gastroparesis referrals often based on misdiagnosis
“Improperly performed GES appears to play a critical role in misdiagnosis” of gastroparesis.
Commentary
Joint effort: CBD not just innocent bystander in weed
‘I visited a legal cannabis dispensary in Massachusetts a few years ago, mostly to see what the hype was about.’
Commentary
The 5-year survival rate for pancreatic cancer is increasing
‘Research is making a difference. And we’re making progress against cancer in general,’ says expert.
Feature
Health plans get very poor scores for access to autoimmune drugs
Three out of four insurance plans use policies that result in significant to severe restriction of access to medications for seven autoimmune...
From the Journals
Exercise training reduces liver fat in patients with NAFLD, even without weight loss
“Prior to our study, it was felt that body weight loss of at least 5% was required in order to significantly improve liver histology. Our findings...
Feature
UnitedHealthcare tried to deny coverage to a chronically ill patient. He fought back, exposing the insurer’s inner workings.
The college student’s medical bills were running nearly $2 million a year.
Feature
Vibrating pill can help treat constipation
The drug-free pill is designed for daily use.
From the Journals
Room for improvement in Barrett esophagus care
Researchers say this is the first study to highlight variation in adherence to these measures at the center and endoscopist levels.
From the Journals
Be aware of hepatic encephalopathy, dementia overlap in older patients with cirrhosis
“There is growing recognition of a so-called ‘liver-brain axis’ ... showing that a range of chronic liver conditions may detrimentally impact...
Commentary
Must-read acute care medicine articles from 2022
“When 2022 began, we started seeing some light at the end of the COVID-19 tunnel.”